Factor structure of the Oxford Shoulder Score: secondary analyses of the UK FROST and PROFHER trial populations

被引:0
|
作者
Simpson, J. [1 ,2 ]
Keding, A. [1 ]
Spencer, S. [3 ]
Brealey, S. [1 ]
Rangan, A. [1 ,2 ]
机构
[1] Univ York, Dept Hlth Sci, York Trials Unit, York, England
[2] Univ York, Hull York Med Sch, York, England
[3] Edge Hill Univ, Hlth Res Inst, Ormskirk, England
关键词
Factor structure; Frozen shoulder; Proximal humeral fracture; Pain; Function; EXPLORATORY FACTOR-ANALYSIS; MINIMUM RANK; NUMBER; QUESTIONNAIRE; FRACTURES; HUMERUS; ADULTS;
D O I
10.1186/s13018-023-04319-x
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Aims Frozen shoulder and proximal humeral fracture can cause pain, stiffness and loss of function. The impact of these symptoms on patients can be measured using the comprehensively validated, 12-item Oxford Shoulder Score (OSS). Evidence suggests that pain and function may have a differential impact on patients' experience of shoulder conditions, and this may be important for clinical management. We therefore explored the factor structure of the OSS within the UK FROST and PROFHER trial populations.Methods We performed exploratory factor analysis (EFA), followed by confirmatory factor analysis (CFA), on baseline UK FROST data from 490 of the 503 trial participants. Data at 6 months post-randomisation were used for 228 of the 250 participants for the PROFHER trial.Results UK FROST factor extraction results, using Velicer's Minimum Average Partial and Horn's Parallel Analysis tests, suggested a unifactorial solution, but two factors were weakly indicated by the less reliable 'Kaiser's eigenvalue > 1' and scree tests. We explored this further using EFA. Eight items (2 to 7, 9 and 10) loaded onto a 'Function' factor, three on a 'Pain' factor (1, 8 and 12) and item 11 cross-loaded. However, one- and two-factor models were rejected in CFA. Factor extraction of PROFHER data at 6 months demonstrated a single first-order factor solution, which was also subsequently rejected in CFA.Conclusion Insufficient evidence was found, within the constraints of the data available, to support the use of 'Pain' and 'Function' sub-scales of the OSS in either patient population.
引用
收藏
页数:7
相关论文
共 28 条
  • [21] Safety and Efficacy of Sitagliptin plus Granulocyte-colony Stimulating Factor in Patients Suffering From Acute Myocardial Infarction (Sitagrami Trial) - Primary and Secondary Analyses
    Brenner, Christoph
    Theiss, Hans D.
    Adrion, Christine
    Grabmaier, Ulrich
    Theisen, Daniel
    von Ziegler, Franz
    Leber, Alexander
    Becker, Alexander
    Sohn, Hae-Young
    Hoffmann, Ellen
    Mansmann, Ulrich
    Steinbeck, Gerhard
    Franz, Wolfgang-Michael
    CIRCULATION, 2015, 132
  • [22] EXPLORING TUMOUR NECROSIS FACTOR INHIBITOR DRUG LEVELS DURING DISEASE ACTIVITY-GUIDED TAPERING IN PATIENTS WITH INFLAMMATORY ARTHRITIS: SECONDARY ANALYSES FROM THE BIODOPT TRIAL
    Sorensen, M.
    Kristensen, S.
    Lauridsen, K. B.
    Duch, K.
    Dreyer, L.
    Christensen, R.
    Hauge, E. M.
    Loft, A. G.
    Rasch, M. Nyhuus Bendix
    Horn, H. C.
    Taylor, P. C.
    Nielsen, K. R.
    Uhrenholt, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 359 - 360
  • [23] Psychometric sensitivity analyses can identify bias related to measurement properties in trials that use patient-reported outcome measures: a secondary analysis of a clinical trial using the disabilities of the arm, shoulder, and hand questionnaire
    Harrison, Conrad J.
    Hossain, Anower
    Bruce, Julie
    Rodrigues, Jeremy N.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2023, 163 : 21 - 28
  • [24] The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up
    Walsh, Timothy S.
    Stanworth, Simon
    Boyd, Julia
    Hope, David
    Hemmatapour, Sue
    Burrows, Helen
    Campbell, Helen
    Pizzo, Elena
    Swart, Nicholas
    Morris, Stephen
    HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (62) : 1 - +
  • [25] Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial
    Scott, Ingrid U.
    Oden, Neal L.
    VanVeldhuisen, Paul C.
    Ip, Michael S.
    Blodi, Barbara A.
    Chan, Clement K.
    Bhargava, Sangeeta
    Figueroa, Maria J.
    Musch, David C.
    Han, Dennis P.
    Sadda, Srinivas R.
    Williams, George A.
    Wisniewski, Stephen
    Gaston, Janelle
    Figueroa, Maria
    Bradley, Lena
    De Stefano, Jodi
    Guan, Eileen
    Hoehn, Anne
    Irazabal, Alexa
    Isman, Sue
    King, Jacquie
    Kondapaka, Radhika
    Kumar, Hamsa
    Lahut, Matt
    Lindblad, Robert
    Lovett, Robin
    Patschak, Michael
    Rothwell, Ro Shauna
    Smith, Rosemary
    Van Dyke, Janet
    Watson, Valerie
    Yesko, Lauren
    Domalpally, Amitha
    Reed, Susan
    Vargo, Pam
    Reed, Cynthia
    Abraham, Prema
    Bement-Stump, Beth
    Callahan, Leah
    Dockter, Mindi
    Livermont, Kristi
    Nixon, Robert
    Parks, Dan
    Steinle, Nathan
    Thompson, Alison
    Yu, Dylan
    Bailey, Steven
    Barth, Jordan
    Campbell, J. Peter
    JAMA OPHTHALMOLOGY, 2019, 137 (12) : 1389 - 1398
  • [26] Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications Secondary Outcomes From the SCORE2 Randomized Clinical Trial
    Scott, Ingrid U.
    VanVeldhuisen, Paul C.
    Ip, Michael S.
    Blodi, Barbara A.
    Oden, Neal L.
    Altaweel, Michael
    Berinstein, Daniel M.
    JAMA OPHTHALMOLOGY, 2018, 136 (04) : 337 - 345
  • [27] Utilization of Immune Checkpoint Inhibitors in Human Epidermal Growth Factor Receptor 2-Negative, Advanced Metastatic, or Unresectable Gastric Cancer Under All Combined Positive Score Grading: Evaluation of Efficacy Based on Individual Patient Data Reconstruction and Secondary Analyses
    Deng, Ning
    Yan, Zhijing
    Wang, Shengpeng
    Song, Menghuan
    Hu, Hao
    CLINICAL THERAPEUTICS, 2025, 47 (02) : 148 - 157
  • [28] Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial
    Aref, Ahmad A.
    Scott, Ingrid U.
    VanVeldhuisen, Paul C.
    King, Jacquie
    Ip, Michael S.
    Blodi, Barbara A.
    Oden, Neal L.
    JAMA OPHTHALMOLOGY, 2021, 139 (12) : 1285 - 1291